Monday, 8 August, 2022
TopicPatanjali

Topic: Patanjali

Flipkart, Patanjali issued show cause notices for closure of operations, CPCB tells NGT

The Central Pollution Control Board said the show cause notice was issued to these units under the Environment (Protection) Act on 8 October.

Baba Ramdev’s Patanjali Ayurved considering bid to be title sponsor of IPL 2020

The move would help the Haridwar-based firm access a global marketing platform, as Patanjali is focusing on exports for its Ayurveda-based FMCG products.

Patanjali can’t use Coronil trademark, says Madras High Court, fines it Rs 10 lakh

The Madras HC was hearing a suit filed by a Chennai firm which claimed it owned the 'Coronil' trademark since 1993. The court also noted Patanjali's drug was not a Covid cure.

Maj Gen GD Bakshi, the defence expert with the loudest war cry on Prime Time TV

A selection of the best news reports, analysis and opinions published by ThePrint this week.

Why Ramdev’s Ruchi Soya shares jumped to Rs 1,535 from Rs 17 in 5 months & are now tanking

Since 29 June, stock has consistently fallen by 5% for 6 consecutive days, triggering lower circuit — levels where trading activity in a stock are suspended following a sharp fall in share prices.

Ramdev says Coronil approved for ‘Covid management’, but govt insists it’s only for immunity

Ramdev said AYUSH ministry has used the term ‘Covid management’ for Patanjali's Coronil kit, but govt letter doesn’t clarify what it means by ‘management’.

Bhutan to not allow sale of Patanjali’s Coronil, says drug not approved by its regulatory body

Bhutan's Drug Regulatory Authority has said there is no cure for Covid-19 yet and it won't allow the sale of any medicine which claims to do so.

Ramdev’s Patanjali shouldn’t sell its medicines as Covid cure, taskforce tells Modi govt

The 17-member taskforce also suggested Patanjali should sell medicines for cough, fever & immunity-boosting as these are the conditions for which it had sought approval.

Ayurveda, FMCG, Covid, controversy — Baba Ramdev and the Patanjali school of marketing

The reaction to Ramdev’s launch of Coronil, which claims to be a ‘cure’ for Covid-19, would be a nightmare for any other company. Not Patanjali, though.

How Ramdev’s Coronil makes social media’s fight against misinformation more difficult

Even as Modi govt asked Patanjali to stop advertising Coronil as a Covid 'cure', platforms did little to stop misleading hashtags, or remove health misinformation.

On Camera

YourTurn

US Special Forces and NATO troops in Afghanistan | Representational image | Commons

US interests in Af-Pak now just ‘transactional’. People can fight their own battles

US drone attack that killed al-Qaeda chief al-Zawahiri shows America can still challenge the Taliban and remain a player in the Af-Pak security discourse.
A suspension pylon in Tamil Nadu | Commons

You thought power subsidy is a Delhi-Punjab problem? Check out Tamil Nadu’s power sector mess

RBI data shows Indian discoms owe power generation firms over Rs 4.5 lakh crore, almost a third of which is owed by Tamil Nadu, where power subsidy cost is twice that of food subsidy.

Defence

The Flying Dolphin — how a former Indian Navy submariner qualified as a commercial pilot 

Vivek Chaudhary retired from the Indian Navy in 2017 after serving on the  Short-Service Commission. After that, his dreams took flight. 

In Kashmir 3 years on, 3 positive changes, 3 things that should’ve happened & 3 that got worse

Kashmir as a crisis has fallen off our headlines and from the top of our collective minds. Which is precisely the most important change for the better.
×